{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:48:56Z","timestamp":1787021336826,"version":"build-2736575974"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1997,9]]},"DOI":"10.1212\/wnl.49.3.686","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T09:29:58Z","timestamp":1336901398000},"page":"686-689","source":"Crossref","is-referenced-by-count":95,"title":["Erythropoietin-associated hypertensive posterior leukoencephalopathy"],"prefix":"10.1212","volume":"49","author":[{"given":"Norman","family":"Delanty","sequence":"first","affiliation":[{"name":"From the Departments of Neurology (Drs. Delanty, Frucht, and Stubgen) and Medicine (Dr. Vaughan), New York Hospital, Cornell Medical Center, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Vaughan","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology (Drs. Delanty, Frucht, and Stubgen) and Medicine (Dr. Vaughan), New York Hospital, Cornell Medical Center, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Frucht","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology (Drs. Delanty, Frucht, and Stubgen) and Medicine (Dr. Vaughan), New York Hospital, Cornell Medical Center, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Stubgen","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology (Drs. Delanty, Frucht, and Stubgen) and Medicine (Dr. Vaughan), New York Hospital, Cornell Medical Center, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1177\/039139889401700102"},{"key":"e_1_3_1_3_2","first-page":"3","volume":"159","year":"1992","unstructured":"Schwartz RB, Jones KM, Kalina P, et al. Hypertensive encephalopathy: findings on CT, MR imaging, and SPECT imaging in 14 cases. AJR Am J Roentgenol 1992;159:379-383.","journal-title":"AJR Am J Roentgenol"},{"key":"e_1_3_1_4_2","first-page":"6","volume":"162","year":"1994","unstructured":"Weingarten K, Barbut D, Filippi C, Zimmerman RD. Acute hypertensive encephalopathy: findings on spin-echo and gradient-echo MR imaging. AJR Am J Roentgenol 1994;162:665-670.","journal-title":"AJR Am J Roentgenol"},{"key":"e_1_3_1_5_2","first-page":"5","volume":"125","year":"1996","unstructured":"Samuels MA. Update in neurology. Ann Intern Med 1996;125:570-576.","journal-title":"Ann Intern Med"},{"key":"e_1_3_1_6_2","first-page":"4","volume":"334","year":"1996","unstructured":"Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494-500.","journal-title":"N Engl J Med"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410400104"},{"key":"e_1_3_1_8_2","first-page":"3","volume":"115","year":"1976","unstructured":"Edvinsson L, Owman C, Sjoberg N-O. Automatic nerves, mast cells, and amine receptors in human brain vessels. A histochemical and pharmacological study. Brain Res 1976;115:377-393.","journal-title":"Brain Res"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-1716.1981.tb06697.x"},{"key":"e_1_3_1_10_2","first-page":"4","volume":"94","year":"1993","unstructured":"Ishimitsu T, Tsukada H, Ogawa Y, Numabe A, Yagi S. Genetic predisposition to hypertension facilitates blood pressure elevation in hemodialysis patients treated with erythropoietin. Am J Med 1993;94:401-406.","journal-title":"Am J Med"},{"key":"e_1_3_1_11_2","first-page":"2","volume":"16","year":"1996","unstructured":"Mayer G, Horl WH. Cardiovascular effects of increasing hemoglobin in chronic renal failure. Am J Nephrol 1996;16:263-267.","journal-title":"Am J Nephrol"},{"key":"e_1_3_1_12_2","first-page":"7","volume":"4","year":"1989","unstructured":"Williams B, Edmunds ME, Thompson JP, Burton PR, Feehally J, Walls J. Does increasing hemoglobin concentration and hematocrit have a pressor effect in dialysis patients? Nephrol Dial Transplant 1989;4:787-791.","journal-title":"Does increasing hemoglobin concentration and hematocrit have a pressor effect in dialysis patients? Nephrol Dial Transplant"},{"key":"e_1_3_1_13_2","first-page":"9","volume":"323","year":"1990","unstructured":"Baskin S, Lasker N. Erythropoietin associated hypertension [letter]. N Engl J Med 1990;323:999.","journal-title":"N Engl J Med"},{"key":"e_1_3_1_14_2","first-page":"1","volume":"62","year":"1987","unstructured":"Massik J, Tang Y-L, Hudak ML, Koehler RC, Traystman RJ, Jones MD Jr. Effect of hematocrit on cerebral blood flow with induced polycythemia. J Appl Physiol 1987;62:1090-1096.","journal-title":"J Appl Physiol"},{"key":"e_1_3_1_15_2","first-page":"6","volume":"14","year":"1991","unstructured":"Muller R, Steffen HN, Brunner R, et al. Changes in the alpha adrenergic system and increase in blood pressure with recombinant human erythropoietin therapy for renal anemia. Clin Invest Med 1991;14:614-622.","journal-title":"Clin Invest Med"},{"key":"e_1_3_1_16_2","first-page":"1","volume":"27","year":"1993","unstructured":"Neusser M, Tepel M, Zidek W. Erythropoietin increases cytosolic free calcium concentration in vascular smooth muscle cells. Cardiovasc Res 1993;27:1233-1236.","journal-title":"Cardiovasc Res"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1647144"},{"key":"e_1_3_1_18_2","doi-asserted-by":"crossref","unstructured":"Bodeboger SM Boger RH Kuhn M Radermacher J Frolich JC. Endothelin release and shift in prostaglandin balance are involved in the modulation of vascular tone by recombinant erythropoietin. J Cardiovasc Pharmacol 1992;20(suppl 12):S25-S28.","DOI":"10.1097\/00005344-199204002-00009"},{"key":"e_1_3_1_19_2","first-page":"8","volume":"45","year":"1994","unstructured":"Caravaca F, Pizarro JL, Arrobas M, Cubero JJ, Garcia MC, Perez-Miranda M. Antiplatelet therapy and the development of hypertension induced by recombinant human erythropoietin in uremic patients. Kidney Int 1994;45:845-851.","journal-title":"Kidney Int"},{"key":"e_1_3_1_20_2","first-page":"1","volume":"52","year":"1993","unstructured":"Tsukuda H, Ishimitsu T, Ogawa Y, Sugimoto T, Yagi S. Direct vasopressor effects of erythropoietin in genetically hypertensive rats. Life Sci 1993;52:1425-1434.","journal-title":"Life Sci"},{"key":"e_1_3_1_21_2","first-page":"2","volume":"39","year":"1991","unstructured":"Heidenrich S, Rahn K-H, Zidek W. Direct vasopressor effect of recombinant human erythropoietin on renal resistance vessels. Kidney Int 1991;39:259-265.","journal-title":"Kidney Int"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1993.1"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/6.1.1"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.49.3.686","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T11:43:08Z","timestamp":1711539788000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.49.3.686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,9]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1997,9]]}},"alternative-id":["10.1212\/WNL.49.3.686"],"URL":"https:\/\/doi.org\/10.1212\/wnl.49.3.686","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,9]]}}}